Peptide record

TPDB27554

Antibacterial Anticancer Antiviral Toxicity standard
36 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB27554
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0 PEPlife
standard
No
A 36-aa standard-residue multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C202H298N50O64
RCGMPV
EL
4450.88
4.07
3
7
14
-5
2.02
-0.875
89.44
Mammalian: 2.8 hour Yeast: 10 min E.coli: 2 min
17990
4.04
13
Residue Composition
number
1
A
0
R
3
N
1
D
0
C
6
E
4
Q
0
G
1
H
2
I
6
L
2
K
0
M
1
F
0
P
4
S
1
T
3
W
1
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 3 D: 1 C: 0 E: 6 Q: 4 G: 0 H: 1 I: 2 L: 6 K: 2 M: 0 F: 1 P: 0 S: 4 T: 1 W: 3 Y: 1 V: 0
Chemical Descriptors
36 reviewed residue count
C202H298N50O64 sequence-only estimate (linear, free termini)
4450.88 sequence-only estimate (linear, free termini)
4.07 sequence-only estimate (linear, free termini)
-5 sequence-only estimate (linear, free termini)
2.02 sequence-only estimate (linear, free termini)
-0.875 sequence-only estimate (linear, free termini)
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
187.28 µM
Cytotoxic
50% Cytotoxicity | 187.28 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Monotherapy With a Low-Dose Lipopeptide HIV Fusion Inhibitor Maintains Long-Term Viral Suppression in Rhesus Macaques. | PLoS Pathog | 2019
Evidence 2 Activity

Activity

50% Cytotoxicity
Toxicity
75.24 µM
Cytotoxic
50% Cytotoxicity | 75.24 | µM | target cell: Human PBMC

Target

Human PBMC

Source & Reference

NA
DBAASP
Monotherapy With a Low-Dose Lipopeptide HIV Fusion Inhibitor Maintains Long-Term Viral Suppression in Rhesus Macaques. | PLoS Pathog | 2019
Additional Detail Fields 6 fields
3.8 ± 0.6 hrs
7919.999999999999
hrs
-0.875
4491.876
4.3